Every one of those 1 sits in a single category, earnings. Cedars-Sinai is most often covered alongside Centers for Medicare & Medicaid Services, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Cedars-Sinai
Every one of those 1 sits in a single category, earnings. Cedars-Sinai is most often covered alongside Centers for Medicare & Medicaid Services, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.5 in the same window. Cedars-Sinai appears in 1 tracked Finance story from September 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Cedars-Sinai. Shared-story counts are live from our verified record — not editorial picks.
Nano-X grew Q2 revenue 37% to $4.2 million but took a $40.7 million impairment and saw cash shrink by nearly half in six months. Management is cutting costs and leaning on distributors, but the cash runway is the central market risk.